Company intelligence / Profile preview

Muir

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Muir Therapeutics is a private biotechnology company based in San Diego, California, focused on developing novel therapies for immunological and inflammatory diseases. Founded in 2023 by a veteran leadership team with deep roots in successful biotech ventures like Receptos and Gossamer Bio, the company operates primarily in stealth mode to advance its early-stage pipeline. Muir is backed by prominent life science investors, including ARCH Venture Partners and Venrock, and leverages expertise in medicinal chemistry and immunology to target high unmet needs. The company aims to create next-generation treatments for chronic inflammatory conditions through precision medicine approaches.

Therapeutic areas: Immunology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Muir.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muir.

Explore the full profile